Recently, most of cancer vaccines were generated against HCC, such as the VEGF vaccine, the DC-based nano-vaccine, as well as a combination of vaccines and ICIs, and all applications have demonstrated the capacity to halt HCC progression (Gao and Zuo, 2023; Lu et al., 2023). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.